Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in from biologics discovery and development through to production and supply chain management.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Proteins & Antibodies

Rapid Analytical Approach for Biologics Characterization Using Mass Photometry

On-demand webinar featuring Dr Racha Majed, Technical Sales Specialist, Refeyn
Read More
Proteins & Antibodies

The Current Landscape of ADC Approvals and Market Trends: Q&A With Mahendra Deonarain, CEO of Antikor Biopharma

While a recent spike in ADC approvals may not last forever, Antikor Biopharma’s Mahendra Deonarain asserts that antibody-drug conjugates are here to stay.
Read More
Proteins & Antibodies

Introducing the Development and Clinical Landscape of Bi and Multispecific Antibodies

While bispecific antibodies target two specific entities, multispecific antibodies can target more than two. The use of these engineered antibodies offers the potential for enhanced therapeutic strategies by simultaneously addressing multiple aspects of a disease.
Read More
Proteins & Antibodies

Cytokines and Immunocytokines in Therapeutic Approaches 

Advancements in cytokine understanding and synthetic immunology enable precise immune modulation, particularly in cancer treatment. However, challenges like short half-lives and side effects impact their wider clinical application.
Read More
Proteins & Antibodies

Post-Event Proceedings - Biologics 2023

Concise and insightful summaries of presentations delivered by prominent thought leaders at Biologics 2023
Read More
Proteins & Antibodies

Multispecific Antibody Development: Interview with Yue Liu, President and Founder of Ab Therapeutics

Discussing using a computational drug discovery platform for the development of multispecific antibody therapeutics.
Read More
Proteins & Antibodies

Handbook for Stem Cell Research

This whitepaper by Sino Biological discusses the different types of stem cells based on their origin and potential, as well as the factors that direct their differentiation toward specific lineages or cell types.
Read More
Proteins & Antibodies

FDA Approves Takeda’s Subcutaneous Ulcerative Colitis mAb

The company can now sell their biologic for ulcerative colitis in a subcutaneous form on the US market.
Read More
Proteins & Antibodies

Navigating the Pharma R&D Regulatory Landscape 2023

Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.
Read More
Proteins & Antibodies

Amgen and Synaffix Pen $2 Billion

Amgen and Synaffix's partnership aims to revolutionise cancer treatment by developing highly targeted antibody-drug conjugates (ADCs).
Read More
Proteins & Antibodies

F-star and Takeda Collaborate to Pave the Way for Next-Generation Cancer Therapies  

F-star Therapeutics and Takeda are partnering to develop next-generation multi-specific antibodies for cancer immunotherapy, building on F-star's advanced platforms.
Read More
Proteins & Antibodies

Accelerating time to market through process innovation

On-Demand Workshop presented by Andreas Castan, Strategic Technologies Director at Cytiva, Cauroline Hausner, Business Development Manager, Aseptic Filling at Cytiva, Ola Tuvesson, Chief Technology Officer at NorthX Biologics & Sofie Östemar, Product Manager, Connected & Continuous at Cytiva
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics